BlackRock, Inc. 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
BLACKROCK INC BLK |
1,212,562 6.100% |
225,990 (+22.91%) |
Filing |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
BLACKROCK INC BLK |
986,572 5.800% |
37,045 (+3.90%) |
Filing |
| 2022-02-02 7:18 pm Purchase |
2021-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
BLACKROCK INC BLK |
949,527 5.600% |
5,109 (+0.54%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
BLACKROCK INC BLK |
944,418 6.100% |
944,418 (New Position) |
Filing |